GlassScriptPhysician profile
Yong T Pak
NPI 1861583437
$1,702.10
in general payments reported to CMS, 2019-2025
31 companies · $461 in 2025
The $461 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $49.16 · 2021: $126 · 2022: $109 · 2023: $134 · 2024: $369 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $964.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $235.15 | 2024-2025 | Sprint Pns System |
| Collegium Pharmaceutical, INC. | $217.01 | 2019-2021 | |
| Stryker Corporation | $203.19 | 2024-2025 | Mild Device Kit, Augment Injectable |
| Stimwave Technologies Incorporated | $108.79 | 2019 | |
| Biotronik Nro, INC. | $93.93 | 2025 | Prospera |
| Nevro Corp. | $77.16 | 2019 | |
| Depuy Synthes Sales INC. | $59.88 | 2019-2023 | Monovisc, Orthovisc |
| Pacira Therapeutics, INC. | $57.77 | 2019-2020 | |
| Smith+Nephew, INC. | $52.03 | 2023 | Pico 7 |
| Baudax Bio INC. | $50.07 | 2021 | |
| Ferring Pharmaceuticals INC. | $41.27 | 2019-2021 | |
| Si-Bone, INC. | $40.40 | 2025 | |
| Globus Medical, INC. | $40.04 | 2025 | Senza |
| Avanos Medical | $38.37 | 2023-2024 | Trivisc Sodium Hyaluronate |
| Pacira Pharmaceuticals Incorporated | $32.89 | 2023 | Zilretta, Exparel |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $29.78 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Grt US Holding, INC. | $28.90 | 2022 | |
| Molnlycke Health Care US, LLC | $28.20 | 2024 | Exufiber Ag+, Avance, Mepilex Border Post-Op Ag |
| Kowa Pharmaceuticals America, INC. | $28.07 | 2022 | |
| Nalu Medical, INC. | $27.35 | 2025 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $24.53 | 2025 | |
| Electronic Waveform Lab, INC. | $23.83 | 2023-2024 | |
| Ossur Americas, INC. | $23.44 | 2025 | |
| Heron Therapeutics, INC. | $21.49 | 2022 | |
| Fidia Pharma USA INC. | $21.30 | 2025 | Hymovis, Triluron |
| Lilly USA, LLC | $19.92 | 2021 | |
| Zimmer Biomet Holdings, INC. | $17.91 | 2024 | Gps III Platelet Concentration System |
| Saluda Medical Americas, INC. | $16.99 | 2025 | Evoke |
| Painteq LLC | $14.89 | 2022 | |
| Orthofix Medical, INC. | $14.20 | 2020 | |
| Mimedx Group, INC. | $13.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yong Pak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.